Image

Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer

Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This randomized controlled trial will evaluate the effect of a preoperative rehabilitation program at home in patients resected for lung cancer, comparing a control group (C group) receiving only chest physiotherapy and a rehabilitation group (R group) receiving both a training program at home and chest physiotherapy

Eligibility

Inclusion Criteria:

  • Patients diagnosed for lung cancer (or highly suspicious for cancer tumor) eligible for resection surgery (lobectomy or pneumonectomy)
  • Age > 18 years
  • Presence of Chronic Obstructive Pulmonary Disease (COPD) stages 2-4 of Gold (forced expiratory volume (FEV )/ forced vital capacity (FVC) <70%, FEV <80% of predicted) and Exertional dyspnea stage MMRC (Medical Research Council) > 1
  • Patients must provide written consent
  • Member of social security scheme

Exclusion Criteria:

  • Patients refusing to participate
  • COPD stage 1 Gold (VEMS >= 80% of the theoretical value)
  • Presenting an operating contraindication during the initial maximal exercise test
  • Presenting cardiac or vascular contraindication to achieve the readaptation program
  • Patient living alone at home
  • Patient with ventilatory assistance at home (oxygen therapy or noninvasive ventilation (NIV))
  • With exercise hypoventilation (PaCO2 >45 mmHg)
  • Cognitive difficulty
  • unable major
  • pregnancy,
  • patients deprived of liberty by a court or administrative decision

Study details
    Lungcancer

NCT03020251

Centre Jean Perrin

29 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.